Estabrook Capital Management’s TITAN PHARMACEUTICAL INC TTP Stock Holding History

Estabrook Capital Management’s Portfolio TTP Stock Details TTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,000	Closed	-$800	–	487
2015 Q2	$800	Hold	1,000	–	–	﹤0.01%	428
2015 Q1	$710	Hold	1,000	–	–	﹤0.01%	436
2014 Q4	$462	Hold	1,000	–	–	﹤0.01%	447
2014 Q3	$555	Hold	1,000	–	–	﹤0.01%	444
2014 Q2	$784	Hold	1,000	–	–	﹤0.01%	443
2014 Q1	$670	Hold	1,000	–	–	﹤0.01%	444
2013 Q4	$605	Hold	1,000	–	–	﹤0.01%	448
2013 Q3	$671	Hold	1,000	–	–	﹤0.01%	447
2013 Q2	$460	Buy	+1,000	New	+$460	﹤0.01%	454

Other funds holding TTP

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Estabrook Capital Management's TTP Position: Q3 2015 in Review

Estabrook Capital Management sold out of TITAN PHARMACEUTICAL INC (TTP) in Q3 2015, closing a stake of 1,000 shares — an estimated $800 sold.

Estabrook Capital Management first reported a position in TTP in Q2 2013 and held it in 9 quarters. The position peaked at $800 in Q2 2015. 2 funds tracked by Wall St. Rank hold TTP as of Q3 2015.

Estabrook Capital Management reported no remaining TITAN PHARMACEUTICAL INC position as of Q3 2015 after selling out during the quarter.
Estabrook Capital Management sold 1,000 TITAN PHARMACEUTICAL INC shares in Q3 2015, an estimated $800.
Estabrook Capital Management first reported a position in TITAN PHARMACEUTICAL INC in Q2 2013 and held it in 9 quarters.
Estabrook Capital Management's TITAN PHARMACEUTICAL INC position peaked at $800 in Q2 2015.
2 funds tracked by Wall St. Rank held TITAN PHARMACEUTICAL INC as of Q3 2015.

Based on Estabrook Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.